Overview
Carrie Fitzgerald is an Urologist in Brick, New Jersey. Dr. Fitzgerald is rated as an Experienced provider by MediFind in the treatment of Urethral Stricture. Her top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Stress Urinary Incontinence, Hydronephrosis, and Ureteroscopy. Dr. Fitzgerald is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
446 Jack Martin Blvd, Brick, NJ 08724
New York University
Lee Zhao is an Urologist in New York, New York. Dr. Zhao is rated as an Elite provider by MediFind in the treatment of Urethral Stricture. His top areas of expertise are Urethral Stricture, Testicular Torsion, Meatal Stenosis, Reconstructive Urology Surgery, and Ureteral Reconstruction.
Temple Faculty Practice Plan Inc
Jay Simhan is an Urologist in Philadelphia, Pennsylvania. Dr. Simhan is rated as a Distinguished provider by MediFind in the treatment of Urethral Stricture. His top areas of expertise are Urethral Stricture, Erectile Dysfunction (ED), Peyronie Disease, Nephrectomy, and Reconstructive Urology Surgery.
NewYork-Presbyterian Medical Group Westchester
Dr. Steven B. Brandes is a world-renowned expert and thought leader in urologic reconstructive surgery. He is currently Chief of Reconstructive Urologic Surgery at New York-Presbyterian/Columbia University Medical Center. Dr. Brandes joined New York-Presbyterian after 17 years at Washington University School of Medicine and Barnes-Jewish Hospital, where he served as Chief of the Section of Reconstructive Urology, Urology Residency Program Director, and Director of the Reconstructive Urology Fellowship Training Program. Dr. Brandes is rated as a Distinguished provider by MediFind in the treatment of Urethral Stricture. His top areas of expertise are Urethral Stricture, Hypospadias, Neurogenic Bladder, Reconstructive Urology Surgery, and Ureteral Reconstruction.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Bilateral HydronephrosisDr. Fitzgerald isAdvanced. Learn about Bilateral Hydronephrosis.
- Bladder StonesDr. Fitzgerald isAdvanced. Learn about Bladder Stones.
- BoilsDr. Fitzgerald isAdvanced. Learn about Boils.
- CarbuncleDr. Fitzgerald isAdvanced. Learn about Carbuncle.
- Congenital Mesoblastic NephromaDr. Fitzgerald isAdvanced. Learn about Congenital Mesoblastic Nephroma.
- Enlarged Prostate (BPH)Dr. Fitzgerald isAdvanced. Learn about Enlarged Prostate (BPH).
- Experienced
- Acute Arterial Occlusion of KidneyDr. Fitzgerald isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute CystitisDr. Fitzgerald isExperienced. Learn about Acute Cystitis.
- Bladder CancerDr. Fitzgerald isExperienced. Learn about Bladder Cancer.
- Bladder Outlet ObstructionDr. Fitzgerald isExperienced. Learn about Bladder Outlet Obstruction.
- ChoriocarcinomaDr. Fitzgerald isExperienced. Learn about Choriocarcinoma.
- Chromophobe Renal Cell CarcinomaDr. Fitzgerald isExperienced. Learn about Chromophobe Renal Cell Carcinoma.